Polymerase Capital is a venture capital firm established in 2021 and based in Seattle, Washington. The firm specializes in investing in seed and early-stage companies within the life sciences sector. By focusing on innovative startups, Polymerase Capital aims to support the development of new technologies and solutions in healthcare and related fields.
Developer of genetic therapy designed to provide treatment for rare disorders and tackle major prevalent diseases affecting people. The company's therapy aims to offer the treatment of osteoarthritis disease as well as improve symptoms and reduce structural disease progression in osteoarthritis patients, thereby enabling patients to avail improved medical care and recover quickly.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.